Ildong Pharmaceutical Co., Ltd. (249420.KS) has a MoatMap StockRank of 21/100 based on Quality (48/100), Value (26/100), and Momentum (37/100) factor scores. The current signal is SELL. Ildong Pharmaceutical Co. (South Korea, Healthcare) faces significant headwinds from 'Dollar Dominance, EM Strain' as an emerging market company, and operates in a pharmaceutical sector without a clear asymmetric macro tailwind.